Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women

6. juli 2022 oppdatert av: Washington University School of Medicine

Pilot Study Utilizing Social Contacts to Facilitate Mammogram Screening Among African American Women

Eliminating racial disparities in breast cancer is a top public health priority. African American (AA) women often present with more advanced and aggressive disease at the time of diagnosis and are more likely to die from breast cancer than any other racial/ethnic group in the United States. Mammogram screening significantly reduces breast cancer mortality by diagnosing cancer at an earlier stage where treatments are more effective. While some AA women do not schedule screening mammograms as recommended by current guidelines, others do not show up for their exams after scheduling them (no-shows). No-shows to cancer screening appointments impose an enormous strain on our limited healthcare resources with negative impact on other patients who could have secured earlier appointments, loss of revenue for hospitals or clinics serving underserved populations and delays in diagnoses and treatment for those who do not have screening. The investigators identified a high no-show rate for screening mammograms at our hospital. AA women were almost three times more likely to no-show for their mammograms compared to White women. Patient's social networks plan an important role in health promotion. In this study, we will pilot an intervention involving patient's social contacts (family, friends, neighbors, etc.) as healthcare facilitators to improve appointment attendance. The investigators seek to determine whether this intervention is feasible and acceptable to patients and whether this intervention will improve attendance rates for screening mammograms among AA women at our institution. If effective, the use of a patient's social contact person as a healthcare facilitator (similar to a patient navigator) would be a readily available and inexpensive resource for other institutions to implement.

Studieoversikt

Status

Fullført

Forhold

Studietype

Intervensjonell

Registrering (Faktiske)

156

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Missouri
      • Saint Louis, Missouri, Forente stater, 63110
        • Washington University School of Medicine

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

40 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria for Patients:

  • Female
  • African American
  • At least 40 years old
  • Scheduled for a screening mammogram within 3 months following initiation of the study
  • Willing and able to provide contact information for two adult social contacts (friends or family members)

Exclusion Criteria for Patients:

-Prior history of breast cancer

Inclusion Criteria for Social Contacts:

  • At least 18 years old
  • Selected by the patient as someone (family member or friend) who would be able to support her in keeping her mammogram appointment

Exclusion Criteria for Social Contacts:

-Less than 18 years of age

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Ikke-randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Patient: Scheduled for mammogram
  • Will be asked to choose 2 social contacts (adult family member or friend identified by the participant as someone who could be engaged by the research team to encourage the participant to attend her mammogram appointment)
  • Will receive reminder(s) from social contact about the screening mammogram appointment
  • Will receive reminder from Breast Health Center about screening mammogram appointment
  • Will be contacted to provide experience with the study
-The social contact will remind patient about screening mammogram appointment
Ingen inngripen: Social Contact of Patient
  • Facilitate enrolled patient to complete the screening mammogram.
  • Will receive information about screening mammograms and resources available at the Breast Imaging Center.
  • Will be contacted approximately 3 days prior to the patient's mammogram appointment.
  • Will be contacted to provide experience with the study

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Feasibility of recruiting patients' social contacts to serve as healthcare facilitators as measured by number of participants enrolled to the study with a social contact that agrees to participate
Tidsramme: Through completion of enrollment (estimated to be 3 months)
-The study is deemed feasible if 80 participants are enrolled to the study and further, if at least 65% of the 80 participants will have a social contact agreeing to participate
Through completion of enrollment (estimated to be 3 months)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Describe demographic characteristics of the social contacts and any associations with patient appointment attendance
Tidsramme: Through mammogram appointment (estimated to be 6 months)
-Use descriptive statistics to present the characteristics of social contacts and regression analysis to determine in association with social contact characteristics and appointment attendance.
Through mammogram appointment (estimated to be 6 months)
Rate of mammography attendance
Tidsramme: Through mammogram appointment (estimated to be 6 months)
Through mammogram appointment (estimated to be 6 months)
Using a structured survey interview, determine the percentage of patients and their social contacts who respond positively (agree or strongly agree) that the intervention helped them keep their scheduled screening mammogram appointment
Tidsramme: Through mammogram appointment (estimated to be 6 months)
-Use descriptive statistics to present response to structured interview questions.
Through mammogram appointment (estimated to be 6 months)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Whitney Hensing, M.D., M.S., Washington University School of Medicine

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

18. mars 2022

Primær fullføring (Faktiske)

30. juni 2022

Studiet fullført (Faktiske)

30. juni 2022

Datoer for studieregistrering

Først innsendt

4. februar 2022

Først innsendt som oppfylte QC-kriteriene

1. mars 2022

Først lagt ut (Faktiske)

11. mars 2022

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

7. juli 2022

Siste oppdatering sendt inn som oppfylte QC-kriteriene

6. juli 2022

Sist bekreftet

1. juli 2022

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Brystkreft

Kliniske studier på Social Contact Reminder

3
Abonnere